Bengaluru: Digital pathology revolutionizes cancer treatment – Experts

Bengaluru: Cancer care hospital HCG has introduced US FDA approved digital pathology solution across all its centres in India on Friday. It ensures greater precision, speed and efficiency in cancer treatment.

HCG was among the first in the country to implement digital pathology in its centre in Bengaluru and gradually it has added this facility at all its centres.

Digital pathology has revolutionised the field of histopathology. It converts the entire glass slide to a digital image which can then be acquired, viewed on a medical grade monitor, annotated, archived, shared and networked across the globe.

During the launch Dr B.S. Ajaikumar, Chairman and CEO, HCG Enterprises Ltd, said, “Pathological diagnosis is one of the most important steps in oncology and at HCG, we have always believed in organ-specific pathologists reviewing the samples. With digital pathology, the way the samples are presented and its magnification are infinitely better than the human eye reviewing them. The biggest advantage, however, is that several people can review the slides at the same time, in separate geographies, to arrive at the best conclusion that would benefit the patient.”

He added that digital pathology is a path breaking concept and will bring in a paradigm shift in cancer treatment.

Dr Veena R., Consultant Pathologist and Head-Histopathologist, Strand Life Sciences also said that with digital Pathology, we have access to all patient information at the click of a button, “